- English
- ePUB (mobile friendly)
- Available on iOS & Android
About this book
Those involved in the drug development process face challenges of efficiency and overall sustainability due in part to high research costs, lengthy development timelines, and late-stage drug failures. Novel clinical trial designs that enroll participants based on their genetics represent a potentially disruptive change that could improve patient outcomes, reduce costs associated with drug development, and further realize the goals of precision medicine.On March 8, 2017, the Forum on Drug Discovery, Development, and Translation and the Roundtable on Genomics and Precision Health of the National Academies of Sciences, Engineering, and Medicine hosted the workshop Enabling Precision Medicine: The Role of Genetics in Clinical Drug Development. Participants examined successes, challenges, and possible best practices for effectively using genetic information in the design and implementation of clinical trials to support the development of precision medicines, including exploring the potential advantages and disadvantages of such trials across a variety of disease areas. This publication summarizes the presentations and discussions from the workshop.
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Information
Table of contents
- COVER PAGE
- TITLE PAGE
- COPYRIGHT PAGE
- TABLE OF CONTENTS
- ACRONYMS AND ABBREVIATIONS
- 1 INTRODUCTION
- 2 OVERARCHING CONSIDERATIONS FOR IMPLEMENTING SUCCESSFUL GENETICS-ENABLED DRUG DEVELOPMENT
- 3 CASE STUDIES IN PRECISION DRUG DEVELOPMENT
- 4 INTEGRATING GENETICS INTO THE DRUG DEVELOPMENT PATHWAY FOR COMPLEX DISEASES
- 5 FINDING INNOVATIVE WAYS TO INTEGRATE GENETIC RESEARCH INTO THE DRUG DEVELOPMENT PROCESS
- 6 REFLECTING BACK AND LOOKING FORWARD: KEY THEMES AND POTENTIAL NEXT STEPS IN GENETICS-ENABLED DRUG DEVELOPMENT
- APPENDIXES